Trial
NCT02721277
SMOFlipid to Lessen the Severity of Neonatal Cholestasis
Phase ITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Florida
Collaborators
—
Condition
Cholestasis
Intervention
SMOFlipid
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-04-17